Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026
Globe Newswire•13/10/2026•16:05 ET
0
Key Highlights
- ➤Pulmonx (LUNG) will report Q3 2026 financial results after market close October 27
- ➤Management’s Q3 results conference call starts at 1:30 p.m. PT / 4:30 p.m. ET
- ➤Pulmonx’s Zephyr Valve is commercially available in more than 25 countries
REDWOOD CITY, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2026 after the close of trading on Tuesday, October 27, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.
A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.
Get started
Create a free account to read the full story.